Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles
Abstract Radiolabeled magnetic nanoparticles are promising candidates as dual-modality-contrast-agents (DMCA) for diagnostic applications. The immunocompatibility of a new DMCA is a prerequisite for subsequent in vivo applications. Here, a new DMCA, namely Fe3O4 nanoparticles radiolabeled with 68Ga,...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/f9189ee69ced4cb9ba8b1377a0369d06 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|